Suppliers and packagers for DURAPREP

DURAPREP

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
3m	DURAPREP	iodine povacrylex; isopropyl alcohol	SPONGE;TOPICAL	021586	NDA	Solventum US LLC	17518-011-07	1 APPLICATOR in 1 CASE (17518-011-07) / 6 mL in 1 APPLICATOR	2006-09-29
3m	DURAPREP	iodine povacrylex; isopropyl alcohol	SPONGE;TOPICAL	021586	NDA	Solventum US LLC	17518-011-08	1 APPLICATOR in 1 CASE (17518-011-08) / 26 mL in 1 APPLICATOR	2006-09-29

Suppliers for the Pharmaceutical Drug: DURAPREP

Last updated: August 1, 2025

Introduction

DURAPREP, a preoperative skin prep solution primarily composed of chlorhexidine gluconate, is widely used in surgical settings to reduce bacterial colonization and prevent surgical site infections (SSIs). As an essential component of infection control protocols, DURAPREP's availability hinges on a reliable network of suppliers capable of delivering high-quality, regulatory-compliant products at scale. This report provides a comprehensive overview of key suppliers for DURAPREP, emphasizing their manufacturing capabilities, quality standards, distribution reach, and market positioning to inform strategic procurement decisions.

Manufacturers and Suppliers of DURAPREP

1. 3M Company

Overview and Role

3M is a global leader in healthcare products, including skin antiseptics. Its division dedicated to surgical and infection prevention products manufactures DURAPREP (marketed under the 3M™ Ioban™ products and other skin prep formulations). 3M's broad manufacturing footprint and rigorous quality standards make it a primary supplier for DURAPREP globally, especially in North America and Europe.

Manufacturing Capabilities

• Advanced manufacturing facilities compliant with GMP (Good Manufacturing Practices).
• Extensive R&D infrastructure supporting formulation improvements and stability.
• Global distribution network ensuring consistent supply chains.

Regulatory Compliance

• Certifications from US FDA, European Medicines Agency (EMA), and other regulatory agencies.
• Adherence to ISO 13485 standards for medical device quality management.

2. Becton, Dickinson and Company (BD)

Overview and Role

BD supplies antiseptic skin preparation products through their Surgical Solutions division. While BD's focus has traditionally centered on alcohol-based prep solutions, recent developments include chlorhexidine-based formulations, making BD a significant contender in the DURAPREP supply chain in some regions.

Manufacturing Capabilities

• State-of-the-art manufacturing facilities with a focus on sterile liquid products.
• Proven expertise in medical device and solution aseptic production.

Regulatory Compliance

• Extensive FDA registration and certification.
• Compliance with international standards including ISO 13485.

3. Johnson & Johnson (J&J)

Overview and Role

J&J's Ethicon division is recognized for surgical products and antiseptic solutions. Their portfolio includes chlorhexidine-based skin prep solutions used in surgical procedures, positioning J&J as a potential supplier or competitor to DURAPREP.

Manufacturing Capabilities

• Large-scale manufacturing facilities with proven expertise in antiseptics.
• Integration of supply chain management ensuring global distribution.

Regulatory Compliance

• Stringent adherence to FDA and EMA regulations.
• Active engagement in pharmacovigilance and compliance audits.

4. Local and Regional Suppliers

In addition to multinational corporations, several regional pharmaceutical and medical supply companies manufacture DURAPREP or similar chlorhexidine-based skin preps to meet local demand. These suppliers often serve markets in Asia, Latin America, and Africa.

Examples

• Shandong Fangte Medical (China)
• Lohmann & Rauscher (Germany)
• Saidar Medical (India)

These companies focus on cost-effective manufacturing while maintaining compliance with regional regulatory standards such as the China Food and Drug Administration (CFDA), Drugs Controller General of India (DCGI), and others.

Quality Standards and Certification

Ensuring product quality and regulatory compliance remains pivotal for suppliers of DURAPREP. Key standards include:

• FDA 21 CFR Part 820 (QSR): For US suppliers.
• ISO 13485: International standard for medical device quality management systems.
• EMA Certification: For European suppliers.
• GMP Compliance: Essential for pharmaceutical and antiseptic manufacturing.
• Batch Traceability and Stability Testing: To ensure consistent efficacy.

Suppliers investing in robust quality management systems are preferred, especially given the critical nature of surgical skin preps.

Distribution Networks and Logistics

Top-tier suppliers maintain global logistics frameworks—integrating warehousing, transportation, and customs clearance—to assure prompt delivery to hospitals, clinics, and surgical centers. Strategic partnerships with logistics providers, compliance with cold chain requirements (if applicable), and local distribution agreements are integral features.

In regions with emerging markets, suppliers often establish regional distribution centers to enhance supply responsiveness, reduce lead times, and manage inventory more efficiently.

Market Dynamics and Supplier Selection Criteria

Key Considerations

• Regulatory Status: Suppliers with approved products in target jurisdictions.
• Manufacturing Capacity: To meet hospital procurement scales.
• Product Quality and Efficacy: Confirmed via clinical outcomes and stability data.
• Cost-effectiveness: Competitive pricing aligned with quality standards.
• Supply Chain Reliability: Proven track record of on-time delivery.
• Strategic Partnerships: Long-term collaborations with healthcare providers.

Emerging Trends

• Synthetic and Alternative Formulations: Development of alcohol-free or alcohol-based prep solutions by existing suppliers.
• Product Differentiation: Offering variants such as alcohol chlorhexidine combinations.
• Sustainability Initiatives: Eco-friendly packaging and production practices.

Conclusion

DURAPREP’s supply chain is primarily anchored by global healthcare giants such as 3M, BD, and J&J, complemented by regional manufacturers that address localized demands. These suppliers uphold high standards of regulatory compliance, product quality, and logistic efficiency, critical for the safe and timely procurement of antiseptic solutions in surgical settings. Strategic sourcing from these manufacturers ensures a reliable supply chain, essential for infection control and surgical outcomes worldwide.

Key Takeaways

• 3M, BD, and Johnson & Johnson are leading global suppliers of DURAPREP or similar chlorhexidine-based skin preps, owing to their extensive manufacturing capabilities and regulatory compliance.
• Regional manufacturers play a vital role in fulfilling local demand, often providing cost-effective alternatives.
• Supplier due diligence should focus on quality certifications (FDA, EMA, ISO 13485), manufacturing capacity, and logistics reliability.
• Emerging market preferences and regulatory landscapes influence supplier selection, with options expanding toward innovative formulations and sustainable practices.
• Robust supplier relationships and diversified sourcing strategies mitigate risks of shortages, ensuring uninterrupted supply in critical surgical contexts.

FAQs

1. What are the leading suppliers of DURAPREP worldwide?
The primary global suppliers include 3M, Becton, Dickinson & Company (BD), and Johnson & Johnson, all of which possess extensive manufacturing and distribution networks compliant with international standards.

2. How do regional manufacturers compare to multinational corporations in supplying DURAPREP?
Regional suppliers often provide cost-effective alternatives with adequate quality standards tailored to local regulatory requirements. However, they may have limited global reach and product traceability compared to multinationals.

3. What quality standards should suppliers of DURAPREP meet?
Suppliers must adhere to GMP, ISO 13485 standards, and obtain certifications from regulatory agencies like the FDA and EMA, ensuring sterility, efficacy, and consistent manufacturing practices.

4. How does supply chain logistics impact DURAPREP availability?
Efficient logistics, including warehousing, transportation, and customs clearance, are critical to maintaining supply continuity. Maintaining diversified distribution channels diminishes procurement risks.

5. Are there emerging alternative suppliers or formulations for DURAPREP?
Yes, innovations include alcohol-based or alcohol-free chlorhexidine preps, created by existing suppliers or new entrants, to meet evolving clinical preferences and regulatory landscapes.

---

Sources:
[1] 3M Healthcare Product Catalogs and Regulatory filings.
[2] Becton, Dickinson & Company official website and product documentation.
[3] Johnson & Johnson Ethicon surgical solutions overview.
[4] Industry reports on antiseptic product manufacturing standards.
[5] Regional regulatory agencies and certifications reports.